Low-density-lipoprotein cholesterol concentrations and risk of incident diabetes: epidemiological and genetic insights from the Framingham Heart Study

Por Andersson, Charlotte, Lyass, Asya, Larson, Martin G., Robins, Sander J., Vasan, Ramachandran S.
Publicado no Diabetologia (2015)

Insulin Resistance and the Relation of a Dyslipidemia to Coronary Heart Disease. The Framingham Heart Study

Por Robins, Sander J., Lyass, Asya, Zachariah, Justin P., Massaro, Joseph M., Vasan, Ramachandran S.
Publicado em 2011

Changes in Erythrocyte Membrane Trans and Marine Fatty Acids between 1999 and 2006 in Older Americans

Por Harris, William S., Pottala, James V., Vasan, Ramachandran S., Larson, Martin G., Robins, Sander J.
Publicado em 2012

Plasma lipid transfer proteins and cardiovascular disease. The Framingham Heart Study

Por Robins, Sander J., Lyass, Asya, Brocia, Robert W., Massaro, Joseph M., Vasan, Ramachandran S.
Publicado em 2013

Relations of Lipid Concentrations to Heart Failure Incidence: The Framingham Heart Study

Por Velagaleti, Raghava S., Massaro, Joseph, Vasan, Ramachandran S., Robins, Sander J., Kannel, William B., Levy, Daniel
Publicado em 2009

Usefulness of the Triglyceride:High Density Lipoprotein versus the Cholesterol:High Density Lipoprotein Ratio for Predicting Insulin Resistance and Cardiometabolic Risk: from the F...

Por Kannel, William B., Vasan, Ramachandran S., Keyes, Michelle J., Sullivan, Lisa M., Robins, Sander J.
Publicado em 2008

Clinical correlates and heritability of erythrocyte eicosapentaenoic and docosahexaenoic acid content in the Framingham Heart Study

Por Harris, William S., Pottala, James V., Lacey, Sean M., Vasan, Ramachandran S., Larson, Martin G., Robins, Sander J.
Publicado em 2012

Relation of Gemfibrozil Treatment and High Density Lipoprotein (HDL) Subpopulation Profile with Cardiovascular Events in the Veterans Affairs HDL Intervention Trial (VA-HIT)

Por Asztalos, Bela F., Collins, Dorothea, Horvath, Katalin V., Bloomfield, Hanna E., Robins, Sander J., Schaefer, Ernst J.
Publicado em 2008

Association of circulating cholesteryl ester transfer protein activity with incidence of cardiovascular disease in the community

Por Vasan, Ramachandran S., Pencina, Michael J., Robins, Sander J., Zachariah, Justin P., Kaur, Guneet, D’Agostino, Ralph B., Ordovas, Jose M.
Publicado em 2009

Red Blood Cell Fatty Acids and Biomarkers of Inflammation: A Cross-sectional Study in a Community-based Cohort

Por Fontes, João D., Rahman, Faisal, Lacey, Sean, Larson, Martin G., Vasan, Ramachandran S., Benjamin, Emelia J., Harris, William S., Robins, Sander J.
Publicado no Atherosclerosis (2015)

Contemporary trends in dyslipidemia in the Framingham Heart Study

Por Ingelsson, Erik, Massaro, Joseph M., Sutherland, Patrice, Jacques, Paul F., Levy, Daniel, D’Agostino, Ralph B., Vasan, Ramachandran S., Robins, Sander J.
Publicado em 2009

Long-term C-Reactive Protein Variability and Prediction of Metabolic Risk

Por Chen, Ting-hsu, Gona, Philimon, Sutherland, Patrice A., Benjamin, Emelia J., Wilson, Peter W.F., Larson, Martin G., Vasan, Ramachandran S, Robins, Sander J
Publicado em 2009

Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart disease

Por Peloso, Gina M., Demissie, Serkalem, Collins, Dorothea, Mirel, Daniel B., Gabriel, Stacey B., Cupples, L. Adrienne, Robins, Sander J., Schaefer, Ernst J., Brousseau, Margaret E.
Publicado em 2010

Clinical Correlates and Heritability of Cystatin C (from the Framingham Offspring Study)

Por Parikh, Nisha I., Hwang, Shih-Jen, Yang, Qiong, Larson, Martin G., Guo, Chao-Yu, Robins, Sander J., Sutherland, Patrice, Benjamin, Emelia J., Levy, Daniel, Fox, Caroline S.
Publicado em 2008

Neck Circumference as a Novel Measure of Cardiometabolic Risk: The Framingham Heart Study

Por Preis, Sarah Rosner, Massaro, Joseph M., Hoffmann, Udo, D'Agostino, Ralph B., Levy, Daniel, Robins, Sander J., Meigs, James B., Vasan, Ramachandran S., O'Donnell, Christopher J., Fox, Caroline S.
Publicado em 2010

Abdominal Subcutaneous and Visceral Adipose Tissue and Insulin Resistance in the Framingham Heart Study

Por Preis, Sarah R., Massaro, Joseph M., Robins, Sander J., Hoffmann, Udo, Vasan, Ramachandran S., Irlbeck, Thomas, Meigs, James B., Sutherland, Patrice, D’Agostino, Ralph B., O’Donnell, Christopher J., Fox, Caroline S.
Publicado em 2010

Clinical and Genetic Factors Associated with Lipoprotein-associated Phospholipase A(2) in the Framingham Heart Study

Por Schnabel, Renate, Dupuis, Josée, Larson, Martin G., Lunetta, Kathryn L., Robins, Sander J., Zhu, Yanyan, Rong, Jian, Yin, Xiaoyan, Stirnadel, Heide A., Nelson, Jeanne J., Wilson, Peter W. F., Keaney, John F., Vasan, Ramachandran S., Benjamin, Emelia J.
Publicado em 2008

Adiposity, Cardiometabolic Risk, and Vitamin D Status: The Framingham Heart Study

Por Cheng, Susan, Massaro, Joseph M., Fox, Caroline S., Larson, Martin G., Keyes, Michelle J., McCabe, Elizabeth L., Robins, Sander J., O'Donnell, Christopher J., Hoffmann, Udo, Jacques, Paul F., Booth, Sarah L., Vasan, Ramachandran S., Wolf, Myles, Wang, Thomas J.
Publicado em 2010

Cardiac Natriuretic Peptides, Obesity, and Insulin Resistance: Evidence from Two Community-Based Studies

Por Khan, Abigail May, Cheng, Susan, Magnusson, Martin, Larson, Martin G., Newton-Cheh, Christopher, McCabe, Elizabeth L., Coviello, Andrea D., Florez, Jose C., Fox, Caroline S., Levy, Daniel, Robins, Sander J., Arora, Pankaj, Bhasin, Shalender, Lam, Carolyn S. P., Vasan, Ramachandran S., Melander, Olle, Wang, Thomas J.
Publicado em 2011

Genome-wide association with select biomarker traits in the Framingham Heart Study

Por Benjamin, Emelia J, Dupuis, Josée, Larson, Martin G, Lunetta, Kathryn L, Booth, Sarah L, Govindaraju, Diddahally R, Kathiresan, Sekar, Keaney, John F, Keyes, Michelle J, Lin, Jing-Ping, Meigs, James B, Robins, Sander J, Rong, Jian, Schnabel, Renate, Vita, Joseph A, Wang, Thomas J, Wilson, Peter WF, Wolf, Philip A, Vasan, Ramachandran S
Publicado em 2007